<DOC>
	<DOCNO>NCT02249468</DOCNO>
	<brief_summary>Difference nutritional status patient mild moderate Alzheimer 's Disease ( AD ) cognitively intact healthy people Asian population</brief_summary>
	<brief_title>An Exploratory Study Compare Differences Nutritional Status Between Patients With Mild Moderate Alzheimer 's Disease ( AD ) Cognitively Intact Healthy People Asian Population</brief_title>
	<detailed_description>The main objective current Asian nutritional status study get insight nutritional status AD patient Asian population Asia . Plasma level several micronutrient fatty acid profile compare patient mild moderate AD cognitively intact healthy control Asian population</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Age ≥ 50 year old Asian ethnicity Group 1 : Cognitively intact healthy volunteer define Cumulative Illness Rating Scale Geriatrics rating ≤ 2 category except category `` psychiatric illness '' rating 0 CDR 0 within 1 year prior visit . OR Group 2a : AD patient clinically diagnose mild AD ( accord National Institute Neurological Communicative Disorders , StrokeAlzheimer 's Disease Related Disorders criterion ( McKhann et al. , 1984 ) ) Clinical Dementia Rating1 OR Group 2b : AD patient clinically diagnose moderate AD ( accord National Institute Neurological Communicative Disorders , StrokeAlzheimer 's Disease Related Disorders criterion ( McKhann et al. , 1984 ) ) Clinical Dementia Rating2 Written inform consent provide accord local regulation . Group 1 : Current diagnosis AD dementia accord National Institute Neurological Communicative Disorders , StrokeAlzheimer 's Disease Related Disorders criterion ( McKhann et al.,1984 ) Group 2 : Change dose within 2 month prior visit AD medication ( e.g . donepezil , rivastigmine , galantamine memantine ) Group 1 2 : Diagnosis significant neurological disease ( Groups 2a 2b : AD ) , include vascular dementia accord National Institute Neurological Communicative Disorders , StrokeAlzheimer 's Disease Related Disorders criterion , cerebral tumour , Huntington 's Disease , Parkinson 's Disease , normal pressure hydrocephalus , seizure , major depression , schizophrenia entity Use vitamins supplement ( vitamin supplement C D allow ) 3 month prior visit Use vitamin B injection Alcohol drug abuse per investigator 's judgement Investigator 's uncertainty willingness ability patient comply protocol requirement Participation study involve investigational market product concomitantly within two week prior entry study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>